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The platirlUm mutation at the C (albino) locus in the mouse is 
a potential model for ocu locutaneous albinism in humans 
other than type JA (tyrosinase-negative) albinism. Although 
tissues from mice homozygous for the mutation display sub-
stantial tyrosinase activi ty, cutaneous and ocular pigmenta-
tion is severely restricted in affected animals. 
Using specific antipeptide antisera, we demonstrate that 
ocular extracts from wild-type mice contain two isoforms of 
tyrosinase bearing either the amino-terminal PEPS epitope 
or the carboxy-terminal PEP7 epitope. The latter isoform 
T yrosinase is a membrane glycoprotein with three dis-tinct cata lytic activities: tyrosine hydroxylase, DOPA oxidase, and indole-conversion [1 J. III both humans and mice, tyrosinase is encoded at the a/billo (C) locus [2]. Mutations that inactivate tyrosinase result in the 
total absence of pigment deposition in the skin, hair, and eyes, a 
condition known as tyrosinase-negative or type IA albinism. At least 
ten other forms of human oculocutaneous albinism are recognized 
that are characterized by substantial tyrosinase activity despite 
markedly diminished cutaneous and ocular pigmentation [3J. Some 
of these forms may, in fact, represent all eles of typc I albinism othcr 
than type IA [4,SJ. 
The platillum (ep) mutation in the laboratory mouse is an allele at 
the albino locus. Micc homozygous for thc platillum mutation have 
almost-white coats and pink cyes [6] . N onetheless, extracts from 
skins of platinum (eP leP) micc display tyrosinase activity higher than 
that found in thc skins of mice with other mutations (e.g., ell illc/lilla, 
['hied') that have much darker coats and eyes [7 ,8J. Townscnd et a/ [7J 
demonstrated that the p/alimwl mutation does not affcct the Km or 
V m" of tyrosinase in tissue extracts from mice, and hypothesized 
that the mutation altcrs the subcellular distribution of tyrosinase. 
By cmploying a combined immunologic and biochemical ap-
proach, we now demonstrate the rresence in ocular extracts from 
wild-typc micc of two isoforms 0 tyrosinasc expressing either the 
amino-terminal epitope PEPS [9J or the carboxy-tcrminal epitopc 
PEP7 [9J. We show that the platillllm mutation rcsults in the appar-
ent loss of the tyrosinase isoform bearing the carboxy-terminal epi-
tope PEP7, and that the tyrosinase prescnt in thc mutant does not 
form the high - molecular-weight multimcric complex present in 
wild-type mice . 
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Abbreviation: TRP, tyrosinase-related protein . 
participates in a high -molecular-weight complex detectable 
on sucrose density gradients. In platinum mice, antiserum to 
the PEP7 epitope fails to recognize any protein species, and 
the high -molecular-weight form of tyrosinase is not detect-
able. Our results support a key role for this high -molecular-
weight complex in melanogenesis, and suggest that muta-
tions that interfere with the ability of tyrosinase to participate 
in a multimeric complex may be a cause of oculocutaneous 
albinism in people. ] flwest Dermatol 101: 137 -140, 1993 
MATERIALS AND METHODS 
Mice C57BL/6J-C/C wild-type mice and C57BL/6J-ep/cp pia/i"llm mice 
were maintained under standard conditions at Texas A&M University labo-
ratory animal facilities . Following sacrifice of the mice, eyes were dissected 
frce, frozen on dry ice, and maintained in a -70'C freezer or on dry ice until 
usc. We have recently shown that the express ion of tyrosinase and tyrosin-
ase-related proteins is maximal on postnatal days 6 - 12 in ocular tissues taken 
from wi ld-type mice. " We confirmed this result, using piarilllllll mice, and 
thus chose co evaluate eyes from wi ld-type and mutant mice at postnatal 
day 7. 
Preparation of Tissue Extracts Frozen eyes were homogenizcd on ice 
with a glass-glass homogenizer in 10% glucose in phosphate-buffered saline 
with 50 ,ug/ mlleupeptin, 20 ,ugjml aprotinin, and 5 rnM benzamidine. on 
ice. Protein content was determined with a commercially available reagent 
(Biorad, Richmond, CAl employing bovine serum albumin as the standard. 
Equal quantities of protein were used in all assays. 
Tyrosinase Activity The tyros ine hydroxylase ac tivity of tyrosinase was 
assayed radiometrically as described previously [10] . For the gel assay of the 
DOPA oxidase activity of tyrosinase, 50,Ltg of tissue homogenate were 
incubated in the presence of 1 % sodium dodecylsulfate at room temperature 
without the addition of mercaptoethanol , and subjected to electrophoresis in 
7.5% polyacrylamide gels . Following equilibration with 0.1 M sodium 
phosphate buffer, pH 6.8, gels were incubated overnight at room tempera-
ture in the same buffer containing 0.5 mgj ml I-DOPA. 
Inununoblotting Equal quantities of protein were boiled in the presence 
of 2% sodium dodecylsulfate and 2% p-mercaptoethanol and subjected to 
electrophoresis and immunoblotting as described [10]. Antisera (all obtained 
from Dr. V. Hearing. NCI) were utilized at the fo llowing dilutions: aPEP7 
(carbQl,:y-tenninus of tyrosinase, used at 1 : 100 dilution) , aPEP5 (amino-
terminus of tyrosinase, 1 : 100), and aPEP8 [carboxy-terminus of tyrosinase-
related protein-2 (TRP-2) j dopachrome tautomerase, 1: 500] [9,11]. 
Sucrose Gradient Density Sedimentation Equal quantities of ocular 
homogenate (1.85 mg protein) were treated with the detergent CHAPS at 
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Table I. Comparison of Wild-Type (GjG) 
Versus Platillum (ePje p) Mice 
Coat color 
Eye color (adult) 
Tyrosinase activity' 
CIC eple P 
Black 
Black 
575.3 ± 104 
Off white 
Pink 
201.1 ± 4 
~ The mean of triplicate determinations. using the tyrosine hydroxylase assay, ex-
pressed as 10' cpm 'H20 released per mg of ocu lar protein per hour ± so. 
2% (w Iv) for 30 min on ice, and insoluble material was removed by centrif-
ugation at 10,000 X g for 15 min. SUl?ernatants were layered on 15 - 40% 
sucrose gradients in 10 mm HEPESj10 mm CaC I2/ 0.25% CHAPS and 
centrifuged for 24 h at 225,000 X g. Tyrosinase activity of collected frac-
tions was determined radiometrically [10] and immunoblotting for tyrosin-
ase and TRP-2 was performed as described [1 2]. These experiments were 
performed three times with essentiall y identical results on each occasion. 
RESULTS 
The phenotypic characteristics and tyrosinase activity of wild type 
and platinum mice are listed in Table I. Despite the presence of 
tyrosinase ac tivity at 35% of wild-type levels, platinum mice have 
pink eyes and extremely light hair (Table I, Fig 1). In other experi-
ments, the values for platinum mice ranged from 25 to 40% of wild 
type, in keeping with results reported for murine skin [8]. 
Immunoblotting with aPEP5, an antiserum specific for the pre-
dicted amino-terminus of tyrosinase [9]. identified a sharp band of 
68 kDa in extracts of both wild-type and platil/um mice (Fig 2A,LeJt). 
In contrast, aPEP7, an antiserum directed against the carboxy-ter-
minal tail of tyrosinase, recognized a broadly migrating band of 
69 - 75 kDa in extracts of wild-type mice, but failed to recognize 
tyrosinase in platinum mice (Fig 2A,right). 
We also performed polyacrylamide gel electrophoresis on sam-
ples treated with sodium dodecylsulfate but without boiling or the 
addition of mercaptoethanol. Tyrosinase was detected by virtue of 
its DOPA-oxidase activ ity, which is preserved under these condi-
tions. The results in Fig 2B demonstrate that the DOPA-oxidase 
activity is not only diminished in platinuln mice, but also migrates 
slightly faster .than its wild-type counterpart. 
Tyrosinase can be purified from a variety of sources in a high-
molecular-weight multimeric form [13 -15]. To investigate the ef-
fects of the platirwIn mutation on the native molecular weight of 
tyrosinase, detergent-soluble extracts from wild-type and pLatil/uIn 
eyes were subjected to sucrose gradient density sedimentation under 
non-denaturing conditions. In extracts from the eyes of wild-type 
mice, tyrosinase migrated as two peaks, of low and high molecular 
Figure 1. Phenotypes of mice. A platillulII (epleP) mouse is shown on the 
right. An albino (e2l je2l) mouse, totally devoid of ocular and coat pigment 
(analagous to type IA tyrosinase-negative albinism in humans), is shown on 
the left for comparison. 
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Figure 2. Electrophoretic ana lysis of tyrosinases. (A) Immunoblotting 
analysis of equal quantities of protein (20 I1g) from wi ld- type (C) and plati-
IIUIII (eP) eyes was performed as described in Materials alld Methods. The lanes 
on the left were searched with aPEPS antiserum (amino-tetminus of tyro-
sinase) and those on the right with aPEP7 (carboxy-terminus of tyrosinase). 
(B) DOPA oxidase stain for tyrosinase. Fifty micrograms of ocular extract 
protein from wild-type (left) and pla/illtlllt (right) mice were denatured with 
sodium dodecylsulfate but without boiling and subjected to sodium 
dodecylsulfate-polyacrylamide gel electrophoresis and staining for DOPA 
oxidase activity. The arrow points to the leading edge of the band in plati/"lIIt 
extracts, which migrates more rapidly than its wild-type counterpart. 
weight, in an approximately 1 : 1 ratio (Fig 3A). In contrast, when 
an extract from platinuln mice was subjected to the identical condi-
tions, only the low - molecular-weight peak of tyrosinase was de-
tected (Fig 3A). 
Immunoblotting analysis (Fig 3B) demonstrated the surprising 
result that the dense peak of tyrosinase activity corresponded to the 
migration of the 69 - 75-kDa species recognized by an tiserum to the 
carboxy-terminal PEP7 epitope . As expected, the platinum extracts 
that lacked this dense peak showed no reactivity with aPEP7. By 
contrast, antiserum to the amino-terminal PEPS epitope specifically 
recognized the 68-kDa band in both wild-type and platil/um ex-
tracts. Its migration corresponded to that of the lighter peak present 
in both types of mice. 
No change was seen in the migration of tyrosinase-related pro-
tein-2 (TRP-2jdopachrome tautomerase), a lthough the absolute 
amount of TRP-2 was elevated in platillltln extracts. This latter 
finding was in keeping with previous reports of increased do-
pachrome tautomerase activity and protein in extracts of tissues 
from mice mutant at th e albino locus [8,16,17]. Due to the ex-
tremely low level of TRP-l detected in ocular tissue by ourselves 
and by Jimenez et al [9] , we could not reliably determine whether 
the platinuln mutation h ad any effect on the migration ofTRP-1 in 
this system. 
DISCUSSION 
Our results demonstrate that ocular extracts from wild-type mice 
contain two isoforms of tyrosinase separable by sucrose density cen-
trifugation, each bearing either the amino-terminal PEPS epitope 
(light form) or the carboxy-terminal PEP7 epitope (dense form). 
These isoforms can also be differentiated by their apparent molecu-
lar weights on sod ium dodecylsulfate-polyacrylamide gel electro-
phoresis: the light form recognized by aPEP5 migrates as 68 kDa, 
whereas the heavy form, recognjzed by aPEP7, migrates as 69-
7~ kDa. The latter form is not detectable in extracts from platill/llll 
n11ce. 
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Figure 3. Sucrose gradient sedimentation analysis. (A) Tyrosinase activi ty 
in gradients of detergent extracts from black (e) and platillllm (0) eyes. The 
bottom of the gradient (densest fractions) are at the right. (B) Immunoblot-
ting of aliquots of sucrose density gradient fractions subjected to sodium 
dodecylsul fate- polyacrylomide gel electrophoresis and searched with 
aPEP7 (carboxy-terminal cpitope of tyrosinase), aPEP5 (amino-termi-
nal epitope of tyros inase), and aPEP8 (carboxy-terminus of TRP-2/do-
pachrome tautomerase) as described in Materia ls alld Met/lads. 
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Numerous investigators have described the presence of alternate 
transcripts of the tyrosinase gene in both murine and human tissues 
[18 - 20J. Whether these alternate transcripts are actually translated 
into protein in normal melanocytic tissues has not, however, been 
investigated systematically, nor has the possibility that tyrosinase is 
subject to alternate post-translational processing such as selective 
proteolysis. Our results suggest that the two isoforms of tyrosinase 
that we detect bear apparently mutually exclusive amino-terminal 
and carboxy-terminal epitopes. The tissue distribution of these iso-
forms also differs. In keeping w ith the results of Jimenez et al (9) , for 
example, we, too, find that whereas tyrosinases bearing the PEP5 
and PEP7 epitopes are present in murine ocular extracts, cultured 
wild-type melanocytes produce only PEP7-positive tyrosinase. 
Our results do not allow us to differentiate readily between the 
possibility that the platill!l111 mutation results in the production of an 
inactive isoform of tyrosinase that also has an altered (truncated?) 
carboxy-terminus and thus lacks the PEP7 epitope, or the alterna-
tive possibility that th is isoform is entirely lacking in platil1um mice. 
Nonetheless, in either case, the high - molecular-weight form of 
tyrosinase, as determined by sucrose density gradient centrifuga-
tion, is absent from extracts of plafhlUlIl mice. 
High - molecular-weight forms of tyrosinase have been detected 
by a number of investigators [13-15]. O ur results suggest that the 
platinum mutalion affects this intermolecular interaction. Jackson 
and colleagues noted that tyrosinase and its related proteins all share 
an EGF-like intraluminal domain that they suggested might be 
important in protein-protein interactions (11). Although our results 
do not disprove this hypothesis, they suggest that the presence of 
the carboxy-terminal cytoplasmic tail of tyrosinase recognized by 
the PEP7 antiserum is critical to the participation of tyrosinase in 
the high - molecular-weight melanogenic complex. Furthermore, 
the extreme hypopigmention of the eyes and coat of platil1um mice 
suggests that the preservation of a functional multimeric complex, 
and not merely the absolute level of tyrosinase activity, is critical to 
maintaining normal levels of cutaneous and ocu lar pigmentation. 
It is now recognized that forms of albinism in humans previously 
characterized as "tyrosinase positive" may, in fact, result from mu-
tations of tyrosinase that do not totally obliterate its activity [4,5]. 
Other forms of oculocutaneous albinism not currently classified as 
type I may, in fact, represent all eles at the albino locus that affect the 
subcellular localization of tyrosinase or its interaction with other 
proteins. Our results suggest that mutations that interfere with the 
abi lity of tyrosinase to form a multimeric complex may have the 
potential to cause some forms of oculocutaneous albinism in 
humans. 
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ANNOUNCEMENT 
A symposium entitled "Melanin: Its Role in Human Photoprotection" will be held at the Hyatt 
Regency Crystal City, Washington, D.C. National Airport, U.S.A., March 11 - 12, 1994. The 
objective of the symposium is to review for the scientific, regulatory, business communities and 
the general public at large the current knowledge of the role of melanin in UV protection. The 
organizing committee is chaired by Dr. Miles R. Chedekel. Dr. Ago B. Ahene is the secretary. 
The registration desk will open at 3:00 p.m. on Thursday, March 10, 1994, and will be followed 
in the evening by a welcoming reception at the Hyatt Regency . The scientific sessions will 
begin at 9:00 a.m. on Friday, March 11,1994. The conference will end on Saturday, March 12, 
1994. 
The tentative program is divided into five plenary sessions and will also include several 
Workshops and Round-table Discussions. The topics include chemistry and physics of mela-
nins, melanin metabolism, natural distribution of melanins and photoprotection, absorptive and 
light-scattering properties of melanins and its precursors, melanin and free-radicals, and round-
table discussions. 
A second announcement and call for papers will be circulated this summer. For further 
information, please contact the Symposium Secretariat, Dr. Ago B. Ahene, Melanin Sympo-
sium Secretariat, 3696 Haven Avenue, Redwood City, California, 94063, U.S.A. Telephone, 
(415) 366-2626; Facsimile, (415) 368-4470. 
